These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 7704922)

  • 21. [Prevention of hepatitis A].
    Wagner G
    Rev Med Suisse Romande; 1993 Mar; 113(3):191-2. PubMed ID: 8386849
    [No Abstract]   [Full Text] [Related]  

  • 22. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines.
    Bryan JP; Nelson M
    Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Active immunization against hepatitis A is now warranted in glucose-6-phosphate dehydrogenase-deficient subjects.
    Ackerman Z; Ablin J; Shouval D
    Am J Gastroenterol; 1996 Feb; 91(2):413. PubMed ID: 8607537
    [No Abstract]   [Full Text] [Related]  

  • 24. Hepatitis A vaccine: evidence of efficacy after exposure.
    Commun Dis Rep CDR Wkly; 1999 Apr; 9(16):139, 142. PubMed ID: 10341473
    [No Abstract]   [Full Text] [Related]  

  • 25. Who should receive hepatitis A vaccine? Considerations for the development of an immunization strategy.
    Margolis HS; Shapiro CN
    Vaccine; 1992; 10 Suppl 1():S85-7. PubMed ID: 1335667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.
    Oldfield EC; Keeffe EB
    Rev Gastroenterol Disord; 2007; 7(1):1-21. PubMed ID: 17392626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic models of hepatitis A virus immunization.
    Meltzer M; Messonnier ML
    Hepatology; 1999 Jul; 30(1):343; author reply 344-5. PubMed ID: 10428626
    [No Abstract]   [Full Text] [Related]  

  • 29. Prospects for the introduction of hepatitis A vaccine into public health use.
    Kane MA
    Prog Med Virol; 1990; 37():96-100. PubMed ID: 2173851
    [No Abstract]   [Full Text] [Related]  

  • 30. A vaccine against hepatitis A--at last.
    Gust ID
    Med J Aust; 1992 Sep; 157(5):345-6. PubMed ID: 1331725
    [No Abstract]   [Full Text] [Related]  

  • 31. Seroprevalence of hepatitis A in children--implications for hepatitis A vaccine.
    Mittal SK; Rastogi A; Rastogi A; Kumar N; Talukdar B; Kar P
    Trop Gastroenterol; 1998; 19(3):120-1. PubMed ID: 9828714
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis A: the vaccine dividend.
    Dienstag JL
    J Infect Dis; 2008 May; 197(9):1220-2. PubMed ID: 18422432
    [No Abstract]   [Full Text] [Related]  

  • 33. Hepatitis A vaccines.
    Shahidah KN
    Med J Malaysia; 2005 Jul; 60 Suppl B():112-5. PubMed ID: 16108190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Public health perspective on vaccine-preventable hepatitis: integrating hepatitis A and B vaccines into public health settings.
    Hershey JH; Schowalter L; Bailey SB
    Am J Med; 2005 Oct; 118 Suppl 10A():100S-108S. PubMed ID: 16271550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hereditable characteristics of attenuated live hepatitis A virus H2 strain].
    Chai SA
    Zhonghua Yi Xue Za Zhi; 1993 Jun; 73(6):335-7, 380. PubMed ID: 8258101
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Observation of live, attenuated hepatitis A vaccines in humans].
    Hu MD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):65-8. PubMed ID: 8394801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Further survey on efficacy of attenuated live hepatitis A vaccines].
    Meng Z; Yao J; Zhao Y
    Zhonghua Yi Xue Za Zhi; 2000 Jan; 80(1):9-11. PubMed ID: 11798728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Trends in research in developing new type of vaccines--aiming at efficacy and safety. Viral hepatitis A vaccine].
    Moritsugu Y
    Nihon Rinsho; 1987 Oct; 45(10):2432-6. PubMed ID: 2834582
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of viral hepatitis A: past, present and future.
    Deinhardt F
    Vaccine; 1992; 10 Suppl 1():S10-4. PubMed ID: 1335635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Type A viral hepatitis. New developments in an old disease.
    Lemon SM
    N Engl J Med; 1985 Oct; 313(17):1059-67. PubMed ID: 2413356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.